Online
|
|
NSE Announcements on Torrent Pharma
Posted by :
MMB MessengerTorrent Pharmaceuticals Ltd. has informed the Exchange regarding a press release dated November 14, 2009, titled "Torrents New Insulin Facility to produce 26 million vials pa for Novo Nordisk". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)....
BSE Announcements on Torrent Pharma
Posted by : MMB MessengerTorrent Pharmaceuticals Ltd has informed BSE that the Company has commissioned a new facility to manufacture human insulin at its Indrad manufacturing complex exclusively for supply to global healthcare major Novo Nordisk. The Company has submitted to BSE a copy of the Press Release dated November 14, 2009 titled "Torrents New Insulin Facility to produce 26 million vials pa for Novo Nordisk"....
Buy Torrent Pharma
Posted by :
insight95in
Torrent Pharma
Buy
Price: Rs328 Target Price (Dec 10): Rs410
Strong 2Q10, exceeds expectation
* Net profit up 54% YoY: Torrent Pharma reported 2Q10 net profit of
Rs740mn up 54% YoY, above our expectation at Rs592mn. This
increase in profits was partly due to higher other operating income and
improvement in margins. The other operating income at Rs250mn
includes dossier income and DEPB benefits. EBITDA margins (excluding
other operating income) at 20% were up c.550bps YoY and 300bps
QoQ. Sales at Rs4.65bn were in line with expectation at Rs4.68bn, up
16% YoY on back of growth in domestic and emerging markets.
* Brazil growth muted, rest of regions in-line: Brazil at Rs870mn
was up 2% YoY against our expectation of 12% growth largely due to
price reductions taken in certain molecules in last 6M. Overall, such
cuts led to a 8% decline in sales, which was offset by 6% volume
growth, 2% contribution of new products and 3% price growth leading
to local currency growth of 3%. This compared to 11% volume growth
in 1Q10 and 8-9% local currency growth. India formulations grew inline
15% YoY. The company continues to maintain high margins on
back of healthy product mix and lower input costs. Heumann at
Rs610mn was up 9% (3% in Euro) vs. our estimate of flat sales. New
products contributed 10% and existing products grew 6% in volumes.
35% of products have completed site-transfers helping improvement in
gross margins. The company has been growing above industry in
covered market. ROW sales grew a solid 42% YoY (30% in constant
currency term) with stable margins. Europe/US sales were in-line.
Russia declined 30% YoY with company booking Rs40m loss due to bad
debts. Contract manufacturing was up 36% YoY to Rs488mn.
* Margin improvement encouraging: While staff costs grew 16% YoY,
raw materials/sales declined. Other expenses were curtailed partly due
to forex loss of Rs100m in 2Q09 vs. Rs10m in 2Q10.
* Maintain Buy: We broadly maintain estimates for FY10-12. Target of
Rs410 is after rolling forward to Dec-10, maintaining PE multiple of
10x.
For more Info Please Call : 9822226867 or
Visit: ww w. insighttechnical. net
ww w. insighttechnical. net has deep domain expertise across our Indian stock market. Investments are made easy with our live NSE and BSE market tips. Our trading tips
covers NSE and BSE .We provide intraday and long term share market calls daily with Equal Emphasising on fundamental and on technicals aspects.Check gainers,losers
,news,penny stock,IPO ,Free tips,trading tricks. INSIGHTTECHNICAL. NET has the resources and nationwide reach to ensure the highest level of personalized service.
INSIGHTTECHNICAL. NET offers services to stock market tips,brokers tips nse ,free intra-day mcx commodities trading tips ,free stock recommendations ,hedge
eqietystomaraws market ,indian share recommendations,indian shares recommendations ,indian stock markets insight,indian stock recommendations ,
indian share market tips,nifty option trading,nifty option,intaday option trading,nifty option,nse market tips,nse/bse stock tips,trading recommendations of indian stocks,indian share market,stock market recommendations by sms,pre-market analysis company,intraday equity tips,intraday stock trading tips,intraday technical analysis,intraday trading nse,intraday trading tips, live market tips,indian equity market ,nse future nifty intraday trading tips,nse tips intraday,sharemarkettipsking,stock intraday tips,financial institutions,hot shares in bse,sharemarketindia,hot stocks bse,nse hot stocks,preferred stock recommendations,hot shares on bse,intraday stock recommendations,technicals of share market,mcxtip,indian stock advisory,nifty stock recomendations,stock trading franchise india,stock market trend history,bse option calculator,hot stocks in indian, share market,hot tips bse market free sms,indianstockcharts,hot indian stocks,hot intraday tips nse,hot intraday tips nse bse,indian stock recommendation for intraday,nifty stock recommendations,technical share market,gold intraday tips,mcx broker tips,hot stock in nse,hot stocks in bse,indian technicals,intraday option trading tips,nri intraday trading,nse intraday recommendations,option calculator nse,share market recommendations,stock market consultant,incdex tips,stock market tips,brokers tips nse ,free intra-day mcx commodities trading tips ,free stock recommendations ,hedge eqietystomaraws market ,indian share recommendations,indian shares recommendations ,indian stock markets insight,indian stock recommendations ,intraday equity tips,intraday stock trading tips,intraday technical analysis,intraday trading nse,intraday trading tips, live market tips,indian equity market ,nse future nifty intraday trading tips,nse tips intraday,sharemarkettipsking,stock intraday tips.
...
31 october quarterly/half yearly results
Posted by : anitharaj
qrtly results on 31oct,saturday2009-10
rs300crore expansion at dahez sez read economictimes use google ...
31 october quarterly/half yearly results
Posted by : anitharajTo consider, inter alia, Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on Consolidated basis as per clause 41 of the Listing Agreement for the quarter and half year ended on September 30, 2009....
Torrent Group to expand pharma facility, set up SEZ
Posted by : anitharaj
Torrent Group to expand pharma facility, set up SEZ
29 Sep 2009, 0043 hrs IST, Himanshu Darji, ET Bureau
AHMEDABAD: It’s all about expansion at Torrent Group, which has interests in pharma and power. Besides chalking out ambitious Rs 4,500-crore plans
for Torrent Power, the group is also expanding its Kadi-based pharma facility and setting up a green field project at upcoming Dahej SEZ.
To expand its existing Indrad facility at Kadi in Mehsana district, Torrent Pharma has approached the regulatory authorities. On the other hand, proposed Dahej SEZ’s unit approval committee has already given nod to Torrent Pharma to set up a formulation and bulk drug manufacturing facility.
Soon, it will start civil work at its 1.64 lakh sq mt land at SEZ where it is also a co-developer with plans to set up 1,500 MW power plant. Torrent Group will pump in close to Rs 300 crore for pharma unit and Rs 4,500 crore for power unit.
Dahej SEZ CEO RJ Shah confirmed that the unit approval committee has cleared the path for Torrent Pharma. However, company officials could not be reached for their comments.
According to the sources close to the developments, Dahej is emerging as a major growth centre for Torrent Group that will have presence through both of its business arms and also eyeing the city gas distribution. It is going to acquire close to 14 lakh sq mt land in Dahej SEZ for power and pharma units.
“Torrent Pharma was considering modest investments in Dahej with facility to manufacture formulations only. Subsequently, it has revised its plans to invest close to Rs 300 crore for both formulations and bulk drug manufacturing. Torrent Pharma is aiming to strengthen its position in the exports market of the US and Europe.
He added that Torrent Pharma would kick of expansion at its Indrad facility as soon as it receives necessary clearances from the authorities.
Indrad facility was set up in 1989 and it complies with WHO, GMP, MHRA and TGA norms. At Indrad, Torrent Pharma has capacity to manufacture 6,000 million tablets, capsules and vials and 15,000 kg of bulk drugs a year.
Torrent Pharma has tied up with Novo Nordisk since August 2005 and part of its parenteral facility is dedicated for the formulation and packaging of insulin, exclusively for Novo Nordisk.
...
30 sept qrtly and half yr results
Posted by : anitharajTo consider, inter alia, Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on Consolidated basis as per clause 41 of the Listing Agreement for the quarter and half year ended on September 30, 2009....
30 sept qrtly and half yr results
Posted by : anitharajTo consider, inter alia, Audited Financial Results on Standalone basis and unaudited Financial Results (with limited review) on Consolidated basis as per clause 41 of the Listing Agreement for the quarter and half year ended on September 30, 2009....
tornt pharma has given breakout, tgt 356
Posted by : the-new-analysttornt pharma has given breakout, tgt 356...
torrent pharma
Posted by : Guesttorrent pharma at 300...
Torrent Pharma 304
Posted by : flashstock05Torrent exceeds tgt ... 304 keep trail of 297 and enjoy the blast,regards flashstock05...
Our rocket Torrent Pharma
Posted by : flashstock05approaching 300 now ..........just minttttttttttttttt, flashstock05...
Torrent Pharma rocks
Posted by : flashstock05Our buy hold pick torrent pharma doing good at 290 ...... over 291 it may reach our tgt today itself ....another of our pick cesc doing gr8 ......enjoy , flashstock05...
Buy Hold Torrent Pharma
Posted by : flashstock05281-277 sl below 274 anticipated tgt 300+ ...........flashstock05...
NSE Announcements on Torrent Pharma
Posted by : MMB MessengerTorrent Pharmaceuticals Ltd. has submitted to the Exchange a copy of the minutes of the Annual General Meeting held on July 29, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)....
